SCHEMBL22985179

SCHEMBL22985179

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2cccc(C#N)c2-c2c(-c3ccc(C(F)(F)F)cc3C#N)cccc2-n2c3ccc(-c4ccc(C)cc4)cc3c3cc(-c4ccc(C)cc4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.39
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
ICMT O60725 1/20 0.35
XDH P47989 2/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SCN9A Q15858 1/20 0.31
MAOA P21397 1/20 0.31
NPC1 O15118 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C19 P33261 1/20 0.31
RAB9A P51151 1/20 0.31
KDM1A O60341 1/20 0.31
KIF11 P52732 1/20 0.30
MAT2A P31153 1/20 0.30
PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985184 0.96 AR (0.36) ARALOX5APFEN1ICMTXDH
SCHEMBL22985183 0.94 AR (0.43) ARALOX5APFEN1ICMTXDH
SCHEMBL22984985 0.94 AR (0.36) ARALOX5APFEN1ICMTXDH
SCHEMBL20848788 0.93 AR (0.42) ARICMTTSHRSMN1; SMN2SCN9A
SCHEMBL22985445 0.92 ALOX5AP (0.36) ARALOX5APFEN1XDHSMN1; SMN2
SCHEMBL22985180 0.92 HTR6 (0.35) ARALOX5APFEN1XDHTSHR
SCHEMBL22984987 0.92 AR (0.37) ARALOX5APFEN1XDHTSHR
SCHEMBL22984988 0.92 ALOX5AP (0.34) ARALOX5APFEN1XDHTSHR
SCHEMBL22985319 0.91 KIF11 (0.40) ARALOX5APFEN1KDM1AKIF11
SCHEMBL22985431 0.90 ALOX5AP (0.36) ARALOX5APFEN1ICMTXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885ALOX5AP 2567/4885FEN1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.